ARTICLE | Company News
Aeson, Hollis-Eden deal
October 16, 2000 7:00 AM UTC
HEPH acquired an exclusive worldwide sublicense to three Aeson patents covering adrenal steroids. HEPH also acquired a 21 percent equity stake in Aeson in exchange for $2 million in cash and 208,681 s...